[Skip to content]

Royal Brompton & Harefield NHS Foundation Trust
About the Trust
Search our Site

Academic Health Science Centre welcomes Royal Brompton and Harefield expertise

13 July 2016

The Trust, along with the Royal Marsden NHS Foundation Trust, has joined the Imperial College Academic Health Science Centre (AHSC), bringing together 21,500 clinicians and other NHS staff, researchers and academics to drive innovation and improved care for the direct benefit of over 1.1 million patients each year in North West London.

With existing members Imperial College London and Imperial College Healthcare Trust, the extended collaboration is set to achieve major advances in health and healthcare by aligning the research, education and clinical services of four organisations with international reputations in all these areas. The new partners bring particular strengths in research and care for cancer, and heart and lung diseases.

The Imperial College AHSC was the UK’s first AHSC, formed in 2007 as a partnership between Imperial College London and Imperial College Healthcare Trust, with Department of Health designation. For the first time, the Imperial College AHSC will now bring together these four organisations that are world leaders in medical research, clinical care and education.

The AHSC will build on existing collaborative projects between the partners, including:

  • the West London Genomic Medicine Centre, which is playing a key role in the successful delivery of the 100,000 Genomes Project
  • the RM Partners Cancer Vanguard, which is developing new models of cancer care
  • joint lung cancer research projects.

Bob Bell, chief executive, said: “This strategic alliance will promote an integrated research vision with the capacity to strengthen translational research into heart and lung disease.

“Patients will be the ultimate beneficiaries, with our combined expertise offering an unparalleled national collaboration. This will improve outcomes now and support enhanced research for future generations.”

Professor Jonathan Weber, Imperial College AHSC director, said: “Our aspiration is to harness the clinical and academic capabilities of the partner organisations to develop new and better approaches to the diagnosis, treatment and care of patients.

“Expansion of the Imperial College AHSC provides exceptional opportunities to create a step-change in our research and education activities, increasing the impact we can have on patient care, not only in our own organisations but across the NHS and beyond.”

Royal Brompton

Sydney Street,
London SW3 6NP
Tel: +44 (0)20 7352 8121